Victory Capital Management Inc. Sells 10,497 Shares of LivaNova PLC (NASDAQ:LIVN)

Victory Capital Management Inc. trimmed its holdings in LivaNova PLC (NASDAQ:LIVN - Free Report) by 1.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 914,737 shares of the company's stock after selling 10,497 shares during the period. Victory Capital Management Inc. owned about 1.68% of LivaNova worth $35,931,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. UMB Bank n.a. lifted its stake in LivaNova by 340.5% during the 1st quarter. UMB Bank n.a. now owns 837 shares of the company's stock valued at $33,000 after acquiring an additional 647 shares in the last quarter. CWM LLC lifted its position in shares of LivaNova by 52.3% during the first quarter. CWM LLC now owns 871 shares of the company's stock valued at $34,000 after purchasing an additional 299 shares in the last quarter. Russell Investments Group Ltd. lifted its position in shares of LivaNova by 17.1% during the fourth quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock valued at $70,000 after purchasing an additional 219 shares in the last quarter. Sterling Capital Management LLC boosted its holdings in LivaNova by 800.6% during the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock worth $75,000 after purchasing an additional 1,441 shares during the last quarter. Finally, Central Pacific Bank Trust Division grew its position in LivaNova by 7.0% in the 1st quarter. Central Pacific Bank Trust Division now owns 4,407 shares of the company's stock worth $173,000 after purchasing an additional 290 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

LivaNova Price Performance

Shares of LivaNova stock traded down $0.83 during trading on Thursday, hitting $43.29. The stock had a trading volume of 759,188 shares, compared to its average volume of 528,004. The company has a current ratio of 1.58, a quick ratio of 1.37 and a debt-to-equity ratio of 0.53. LivaNova PLC has a 12 month low of $32.48 and a 12 month high of $57.35. The firm has a market cap of $2.36 billion, a price-to-earnings ratio of -10.58 and a beta of 0.90. The business's 50-day moving average is $44.71 and its 200 day moving average is $43.08.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Wolfe Research raised LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 target price for the company in a report on Tuesday, May 20th. Wall Street Zen downgraded LivaNova from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 8th. Robert W. Baird lifted their target price on LivaNova from $55.00 to $61.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. Needham & Company LLC reissued a "buy" rating and issued a $64.00 price target on shares of LivaNova in a report on Tuesday, May 13th. Finally, Barclays lowered their price target on shares of LivaNova from $56.00 to $55.00 and set an "equal weight" rating on the stock in a report on Thursday, May 8th. One research analyst has rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $59.29.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.